Contribution of a plasmid-borne blaOXA-58 gene with its hybrid promoter provided by IS1006 and an ISAba3-like element to beta-lactam resistance in acinetobacter genomic species 13TU
- PMID: 20516281
- PMCID: PMC2916316
- DOI: 10.1128/AAC.00128-10
Contribution of a plasmid-borne blaOXA-58 gene with its hybrid promoter provided by IS1006 and an ISAba3-like element to beta-lactam resistance in acinetobacter genomic species 13TU
Abstract
The contribution of the blaOXA-58 gene and its promoter to beta-lactam resistance has not been validated in Acinetobacter spp. other than Acinetobacter baumannii. We identified a multidrug-resistant (including carbapenem resistance) Acinetobacter genomic species 13TU in which blaOXA-58 was the only detected carbapenemase gene. The blaOXA-58 gene was plasmid located, flanked by ISAba3 (downstream) and an ISAba3-like element (upstream). An IS1006 element was inserted into ISAba3-like (IS1006-DeltaISAba3-like) to generate a hybrid promoter for blaOXA-58, with a -35 promoter located in IS1006 and a -10 promoter in ISAba3-like. The reference strain of Acinetobacter genomic species 13TU, ATCC 17903, revealed higher MICs of amoxicillin, ticarcillin, and piperacillin and heteroresistance to imipenem and meropenem when it was transformed with a shuttle vector containing a fragment encompassing DeltaISAba3-like-blaOXA-58, compared to the same host containing only blaOXA-58. When the fragment was changed from DeltaISAba3-like-blaOXA-58 to IS1006-DeltaISAba3-like-blaOXA-58, the ATCC 17903 transformant revealed a markedly higher level of blaOXA-58 transcription (12-fold), increased cefuroxime and piperacillin-tazobactam MICs, and homoresistance to imipenem and meropenem. Different roles of the insertion elements preceding the blaOXA-58 gene in Acinetobacter genomic species 13TU are demonstrated. The ISAba3-like--blaOXA-58 construct can mediate resistance to penicillin derivatives but only heteroresistance to carbapenems. The insertion of IS1006 into ISAba3-like, generating a hybrid promoter, could further enhance the transcription of blaOXA-58 and mediate homoresistance to carbapenems and also enhanced resistance to piperacillin-tazobactam.
Figures
Similar articles
-
Acquisition of a plasmid-borne blaOXA-58 gene with an upstream IS1008 insertion conferring a high level of carbapenem resistance to Acinetobacter baumannii.Antimicrob Agents Chemother. 2008 Jul;52(7):2573-80. doi: 10.1128/AAC.00393-08. Epub 2008 Apr 28. Antimicrob Agents Chemother. 2008. PMID: 18443121 Free PMC article.
-
Molecular epidemiology of carbapenem non-susceptible Acinetobacter nosocomialis in a medical center in Taiwan.Infect Genet Evol. 2015 Apr;31:305-11. doi: 10.1016/j.meegid.2015.02.017. Epub 2015 Feb 24. Infect Genet Evol. 2015. PMID: 25724091
-
Carbapenem Resistance in Acinetobacter nosocomialis and Acinetobacter junii Conferred by Acquisition of blaOXA-24/40 and Genetic Characterization of the Transmission Mechanism between Acinetobacter Genomic Species.Microbiol Spectr. 2022 Feb 23;10(1):e0273421. doi: 10.1128/spectrum.02734-21. Epub 2022 Feb 9. Microbiol Spectr. 2022. PMID: 35138195 Free PMC article.
-
Differences in carbapenem resistance genes among Acinetobacterbaumannii, Acinetobacter genospecies 3 and Acinetobacter genospecies 13TU in Taiwan.Int J Antimicrob Agents. 2010 May;35(5):439-43. doi: 10.1016/j.ijantimicag.2009.11.020. Epub 2010 Jan 27. Int J Antimicrob Agents. 2010. PMID: 20106635
-
[The high level resistance to carbapenems in Acinetobacter baumannii is a multifactorial problem].Enferm Infecc Microbiol Clin. 2001 Aug-Sep;19(7):336-8. doi: 10.1016/s0213-005x(01)72653-5. Enferm Infecc Microbiol Clin. 2001. PMID: 11747791 Review. Spanish. No abstract available.
Cited by
-
The deficiency of poly-β-1,6-N-acetyl-glucosamine deacetylase trigger A. baumannii to convert to biofilm-independent colistin-tolerant cells.Sci Rep. 2023 Feb 16;13(1):2800. doi: 10.1038/s41598-023-30065-5. Sci Rep. 2023. PMID: 36797306 Free PMC article.
-
Structural Basis of PER-1-Mediated Cefiderocol Resistance and Synergistic Inhibition of PER-1 by Cefiderocol in Combination with Avibactam or Durlobactam in Acinetobacter baumannii.Antimicrob Agents Chemother. 2022 Dec 20;66(12):e0082822. doi: 10.1128/aac.00828-22. Epub 2022 Nov 15. Antimicrob Agents Chemother. 2022. PMID: 36377939 Free PMC article.
-
How Do Transposable Elements Activate Expression of Transcriptionally Silent Antibiotic Resistance Genes?Int J Mol Sci. 2022 Jul 22;23(15):8063. doi: 10.3390/ijms23158063. Int J Mol Sci. 2022. PMID: 35897639 Free PMC article. Review.
-
Global Threat of Carbapenem-Resistant Gram-Negative Bacteria.Front Cell Infect Microbiol. 2022 Mar 15;12:823684. doi: 10.3389/fcimb.2022.823684. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35372099 Free PMC article. Review.
-
Resistance traits and molecular characterization of multidrug-resistant Acinetobacter baumannii isolates from an intensive care unit of a tertiary hospital in Guangdong, southern China.Int Microbiol. 2022 Aug;25(3):471-479. doi: 10.1007/s10123-022-00233-0. Epub 2022 Jan 31. Int Microbiol. 2022. PMID: 35098390
References
-
- Chang, H. C., Y. F. Wei, L. Dijkshoorn, M. Vaneechoutte, C. T. Tang, and T. C. Chang. 2005. Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region. J. Clin. Microbiol. 43:1632-1639. - PMC - PubMed
-
- Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 8th ed. CLSI document M7-A8. Clinical and Laboratory Standards Institute, Wayne, PA.
-
- Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing: 20th informational supplement. CLSI document M100-S20. Clinical and Laboratory Standards Institute, Wayne, PA.
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Miscellaneous
